Back to search
FDAFDA · Food and drugs·Recall number D-1321-2022

Pataday, Once Daily Relief, Olopatadine hydrochloride ophthalmic solution 0.2%, Antihistamine, Eye Allergy Itch Relief, Once Daily, Sterile, 2.5 mL (0.085 FL OZ) bottle per box, Alcon, NDC 0065-8150-01.

Published August 17, 2022 · Recall initiated: June 29, 2022

Summary

FDA records drug Class II recall D-1321-2022, published August 17, 2022 and initiated June 29, 2022. Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office; Status: Terminated; Reported quantity: 1 box; Lot: Part# 00065815001. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: products were stored outside the drug label specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email if PATADAY ONCE DAILY RELIEF has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PATADAY ONCE DAILY RELIEF
Manufacturer
Mckesson Medical-Surgical Inc. Corporate Office
Distributor
Nationwide in the USA.
Lot
Part# 00065815001
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pataday, Once Daily Relief, Olopatadine hydrochloride ophthalmic solution 0.2%, Antihistamine, Eye Allergy Itch Relief, Once Daily, Sterile, 2.5 mL (0.085 FL OZ) bottle per box, Alcon, NDC 0065-8150-01. recalled?

Yes. FDA published recall D-1321-2022 on August 17, 2022. Reported hazard: CGMP Deviations: products were stored outside the drug label specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PATADAY ONCE DAILY RELIEF.